1. Protective effect of berberine against cardiac ischemia/reperfusion injury by inhibiting apoptosis through the activation of Smad7
   Weidong Yao et al, 2017, Molecular and Cellular Probes CrossRef
2. An in vitro comparative study of the antioxidant activity and SIRT1 modulation of natural compounds
   Jonathan Fusi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
3. Portulacaoleraceal extract alleviates trinitrobenzene sulfonic acid-induced colitis in rats
   Yun Huang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
4. Periplaneta americana Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Keap1/Nrf-2 Activation, Intestinal Barrier Function, and Gut Microbiota Regulation
   Xuewei Ma et al, 2018, Front. Pharmacol. CrossRef
5. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS
   Lina Huang et al, 2018, International Immunopharmacology CrossRef
6. Phytochemicals and inflammatory bowel disease: a review
   Imam Hossen et al, 2019, Critical Reviews in Food Science and Nutrition CrossRef
7. iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis
   Yan-hong Li et al, 2019, European Journal of Pharmacology CrossRef
8. Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease
   Jiao Peng et al, 2019, Front. Pharmacol. CrossRef
9. Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer
   Dianbo Yao et al, 2019 CrossRef
10. Berberine Protects Mice Against Dextran Sulfate Sodium-Induced Colitis by Activating mTORC1 Pathway
    Qingjun Li et al, 2019, Front. Pharmacol. CrossRef
11. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions.
    Heng Li et al, 2020, Acta Pharm Sin B CrossRef
12. Dexmedetomidine Attenuates Orthotopic Liver Transplantation-Induced Acute Gut Injury via α2-Adrenergic Receptor-Dependent Suppression of Oxidative Stress
    Peibiao Lv et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
13. Pomegranate peel polyphenols reduce chronic low-grade inflammatory responses by modulating gut microbiota and decreasing colonic tissue damage in rats fed a high-fat diet
    Ruiqi Zhao et al, 2019, Food Funct. CrossRef
14. Circadian Pharmacological Effects of Berberine on Chronic Colitis in Mice: Role of the Clock Component Rev-erbα
    Ziyue Zhou et al, 2019, Biochemical Pharmacology CrossRef
15. Improvement of Oxazolone-Induced Ulcerative Colitis in Rats Using Andrographolide
    Liuhong Zhang et al, 2019, Molecules CrossRef
16. null
    Muna Ali Abdalla et al, 2020 CrossRef
17. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota
    Haitao Chen et al, 2020, Biomedicine & Pharmacotherapy CrossRef
18. Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders
    Wei-Jia Kong et al, 2020, Pharmacology & Therapeutics CrossRef
19. Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines
    Peng-De Lu et al, 2020, Chin Med CrossRef
20. Antitumor Drug Combretastatin-A4 Phosphate Aggravates the Symptoms of Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
    Zhengshan Tang et al, 2020, Front. Pharmacol. CrossRef
21. Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer
    Jamal Hallajzadeh et al, 2020, Med Oncol CrossRef
22. Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis
    Heng Li et al, 2020, Cell Death Dis CrossRef
23. Antioxidant Analogue 6-Amino-2,4,5-Trimethylpyridin-3-ol Ameliorates Experimental Colitis in Mice
    Hoyul Lee et al, 2020, Dig Dis Sci CrossRef
24. Goldenseal (Hydrastis canadensis L.) and its active constituents: a critical review of their efficacy and toxicological issues
    Sudip Kumar Mandal et al, 2020, Pharmacological Research CrossRef
25. Berberine inhibits intestinal epithelial barrier dysfunction in colon caused by peritoneal dialysis fluid by improving cell migration
    Dongliang Zhang et al, 2020, Journal of Ethnopharmacology CrossRef
26. Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis
    Pedro A. Ruiz Castro et al, 2020, J Inflamm CrossRef
27. Anticolitic Effect of Berberine in Rat Experimental Model: Impact of PGE2/p38 MAPK Pathways
    Li Jia et al, 2020, Mediators of Inflammation CrossRef
28. Huang Lian for ulcerative colitis
    Tinglin Li et al, 2020 CrossRef
29. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies.
    Yuhan Yang et al, 2021, J Ethnopharmacol CrossRef
30. Berberine Suppresses Colonic Inflammation in Dextran Sulfate Sodium–Induced Murine Colitis Through Inhibition of Cytosolic Phospholipase A2 Activity
    Lixiang Zhai et al, 2020, Front. Pharmacol. CrossRef
31. Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells
    Xinyu Xiong et al, 2021, Biomedicine & Pharmacotherapy CrossRef
32. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine
    Lingzhi Zhang et al, 2021, Mol. Pharmaceutics CrossRef
33. Berberine Administration in Treatment of Colitis: A Review
    Milad Ashrafizadeh et al, 2020, CDT CrossRef
34. Development of an Advanced Multicellular Intestinal Model for Assessing Immunomodulatory Properties of Anti-Inflammatory Compounds
    Diego Marescotti et al, 2021, Front. Pharmacol. CrossRef
35. Phytochemicals Targeting JAK–STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models
    Sun Young Moon et al, 2021, Molecules CrossRef
36. Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology
    Yan Jiang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
37. In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis
    Xiaolu Liu et al, 2021, Front. Pharmacol. CrossRef
38. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
    Linshan Duan et al, 2021, Front. Pharmacol. CrossRef
39. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases
    Menghang Zu et al, 2021, Advanced Drug Delivery Reviews CrossRef
40. Influence of fruit-based beverages on efficacy of Lacticaseibacillus rhamnosus GG (Lactobacillus rhamnosus GG) against DSS-induced intestinal inflammation
    Srijita Sireswar et al, 2021, Food Research International CrossRef
41. Berberine Acts on C/EBPβ/lncRNA Gas5/miR-18a-5p Loop to Decrease the Mitochondrial ROS Generation in HK-2 Cells
    Jiang Xu et al, 2021, Front. Endocrinol. CrossRef
42. Toxic effects of copper on the jejunum and colon of pigs: mechanisms related to gut barrier dysfunction and inflammation influenced by the gut microbiota
    Jianzhao Liao et al, 2021, Food Funct. CrossRef
43. Natural-derived alkaloids exhibit great potential in the treatment of ulcerative colitis
    Cailan Li et al, 2021, Pharmacological Research CrossRef
44. Green-synthetized selenium nanoparticles using berberine as a promising anticancer agent
    Mohamed S. Othman et al, 2021, Journal of Integrative Medicine CrossRef
45. Mitigative effects of Eleutheroside E against the mechanical barrier dysfunction induced by soybean agglutinin in IPEC‐J2 cell line
    Bao Zhao et al, 2022, Animal Physiology Nutrition CrossRef
46. Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia
    Meijuan Li et al, 2022, Eur Arch Psychiatry Clin Neurosci CrossRef
47. An oral pH-activated “nano-bomb” carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis
    Mei Yang et al, 2022, Biomater. Sci. CrossRef
48. Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders
    Qiukai Lu et al, 2022, Pharmacol. Rep CrossRef
49. Berberine represses Wnt/β-catenin pathway activation via modulating the microRNA-103a-3p/Bromodomain-containing protein 4 axis, thereby refraining pyroptosis and reducing the intestinal mucosal barrier defect induced via colitis
    Xun Zhao et al, 2022, Bioengineered CrossRef
50. Concerted action of berberine in the porcine intestinal epithelial model IPEC‐J2: Effects on tight junctions and apoptosis
    Valeria Cornelius et al, 2022, Physiological Reports CrossRef
51. Holism of Chinese herbal medicine prescriptions for inflammatory bowel disease: A review based on clinical evidence and experimental research
    Siyuan Zhang et al, 2022, Phytomedicine CrossRef
52. Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function
    Yi-Feng Wang et al, 2022, DDDT CrossRef
53. Protective Effects of Lactobacillus rhamnosus Peptides Against DSS-Induced Inflammatory and Oxidative Damages in Human Colonic Epithelial Cells Through NF-κB/Nrf2/HO-1 Signaling Pathway
    Dan Luo et al, 2022, Int J Pept Res Ther CrossRef
54. Hederacoside C ameliorates colitis via restoring impaired intestinal barrier through moderating S100A9/MAPK and neutrophil recruitment inactivation
    Zheng-xia Zha et al, 2022, Acta Pharmacol Sin CrossRef
55. Lactobacillus casei-fermented blueberry pomace ameliorates colonic barrier function in high fat diet mice through MAPK-NF-κB-MLCK signaling pathway
    Yuxin Cheng et al, 2022, Journal of Functional Foods CrossRef
56. Berberine Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis and Inhibits the Secretion of Gut Lysozyme via Promoting Autophagy
    Xiaofan Xu et al, 2022, Metabolites CrossRef
57. Probiotics from Dairy Products on Intestinal Barrier Function Using Caco-2 Cells under Microscope
    Peilin Yao et al, 2022, BioMed Research International CrossRef
58. TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis
    Sujie Liu et al, 2022, BioMed Research International CrossRef
59. Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies
    Shuangyuan Hu et al, 2022, Front. Pharmacol. CrossRef
60. Anatabine attenuates ovalbumin-induced asthma via oxidative stress and inflammation mitigation and Nrf2/HO-1 signaling upregulation in rats
    Walied Abdo et al, 2022, Life Sciences CrossRef
61. Plants in vitro propagation with its applications in food, pharmaceuticals and cosmetic industries; current scenario and future approaches
    Ammarah Hasnain et al, 2022, Front. Plant Sci. CrossRef
62. Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy
    Cuipeng Zhu et al, 2022, Front. Immunol. CrossRef
63. Fabrication, in Vitro, and in Vivo Characterization of Mucoadhesive Berberine-Loaded Blended Wafers for Treatment of Chemotherapy-Induced Oral Mucositis
    Hamed Vaezi et al, 2022, AAPS PharmSciTech CrossRef
64. Berberine increases stromal production of Wnt molecules and activates Lgr5+ stem cells to promote epithelial restitution in experimental colitis
    Zecheng Luo et al, 2022, BMC Biol CrossRef
65. Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
    Yaoyuan Zhang et al, 2023, Front. Nutr. CrossRef
66. Peptide-metal Nanohybrids (PMN): Promising entities for combating neurological maladies
    Avneet Kour et al, 2023, Advances in Colloid and Interface Science CrossRef
67. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism
    Xiongjie Sun et al, 2023, Biomedicine & Pharmacotherapy CrossRef
68. Neuroprotective Effect of Berberine by amelioration of behavioural, biochemical and histological anomalies on Valproate Induced Autistic features in Experimental Animals
    Sagarika Majhi et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef
69. The anti-inflammatory and anti-apoptotic effects of Achillea millefolium L. extracts on Clostridioides difficile ribotype 001 in human intestinal epithelial cells
    Hamideh Raeisi et al, 2024, BMC Complement Med Ther CrossRef
70. Targeting beta-catenin signaling for prevention of colorectal cancer – Nutraceutical, drug, and dietary options
    Simon Bernard Iloki Assanga et al, 2023, European Journal of Pharmacology CrossRef
71. null
    Eswara Rao Puppala et al, 2023 CrossRef
72. Furan based synthetic chalcone derivative functions against gut inflammation and oxidative stress demonstrated in in-vivo zebrafish model
    S.P. Ramya Ranjan Nayak et al, 2023, European Journal of Pharmacology CrossRef
73. Shaoyao Decoction reduced T lymphocyte activation by regulating of intestinal flora and 5-hydroxytryptamine metabolism in ulcerative colitis
    Jianhua Zhen et al, 2024, Chin Med CrossRef
74. Harnessing nature’s pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis
    You Huang et al, 2024, Front. Pharmacol. CrossRef